A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration Study

BACKGROUND: Insulin-like growth factor-1 receptor (IGF-1R) is implicated in the pathogenesis of rhabdomyosarcoma (RMS), osteosarcoma (OS), and synovial sarcoma (SS). The authors conducted a multi-institutional phase 2 trial of the monoclonal antibody R1507 in patients with various subtypes of recurr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer
Main Authors: Pappo, Alberto S., Vassal, Gilles, Crowley, John J., Bolejack, Vanessa, Hogendoorn, Pancras C. W., Chugh, Rashmi, Ladanyi, Marc, Grippo, Joseph F., Dall, Georgina, Staddon, Arthur P., Chawla, Sant P., Maki, Robert G., Araujo, Dejka M., Geoerger, Birgit, Ganjoo, Kristen, Marina, Neyssa, Blay, Jean-Yves, Schuetze, Scott M., Chow, Warren A., Helman, Lee J.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7009782/
https://ncbi.nlm.nih.gov/pubmed/24797726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28728
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki